EverSource Wealth Advisors’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44K Buy
6,909
+5,404
+359% +$37.6K ﹤0.01% 1999
2025
Q4
$10.6K Buy
1,505
+590
+64% +$3.56K ﹤0.01% 2765
2025
Q3
$5.03K Buy
915
+727
+387% +$3.56K ﹤0.01% 3144
2025
Q2
$972 Sell
188
-54
-22% -$324 ﹤0.01% 3745
2025
Q1
$1.61K Buy
242
+118
+95% +$897 ﹤0.01% 3023
2024
Q4
$914 Buy
124
+11
+10% +$79 ﹤0.01% 2999
2024
Q3
$791 Buy
113
+45
+66% +$270 ﹤0.01% 2772
2024
Q2
$375 Sell
68
-107
-61% -$645 ﹤0.01% 2943
2024
Q1
$1.08K Buy
175
+20
+13% +$135 ﹤0.01% 2553
2023
Q4
$1.21K Buy
+155
New +$999 ﹤0.01% 2331

Other funds holding LFST

EverSource Wealth Advisors's LFST Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Lifestance Health (LFST) stake by 359% in Q1 2026, buying an estimated $37.6K and bringing the position to 6,909 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

EverSource Wealth Advisors first reported a position in LFST in Q4 2023 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • EverSource Wealth Advisors held 6,909 shares of Lifestance Health worth $44K as of Q1 2026.
  • EverSource Wealth Advisors bought 5,404 Lifestance Health shares in Q1 2026, an estimated $37.6K.
  • Lifestance Health made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #1999 holding.
  • EverSource Wealth Advisors first reported a position in Lifestance Health in Q4 2023 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.